ReviewToxics2026
Microplastics in Foods Intended for Health Purposes: From Dietary Supplements to Clinical Nutrition Products.
Review in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microplastics (MPs) are pervasive contaminants that have been detected throughout the food chain. Their presence raises concerns in foods intended for health-related purposes, as these products are often consumed by vulnerable populations such as infants, older adults, and patients requiring clinical nutrition support. These groups may be more susceptible to contaminant exposure and may rely heavily on specialized foods. Therefore, understanding the occurrence and potential risks of MPs in such products is important. This review summarizes the current state of knowledge regarding the presence, sources, and health implications of plastic particles in several categories of health-oriented foods, including dietary supplements, medicinal herbs, plant-based beverages, honey, infant formulas, and clinical nutrition products, including enteral and parenteral formulations. Microplastics have been reported across these matrices. Fibers and fragments dominate, and common polymers include polyamide, polyethylene, polypropylene, and poly(ethylene terephthalate). These particles can originate from polluted water, soil, and air, as well as from production processes, packaging wear, and clinical delivery systems. Current evidence suggests that improving methodological consistency and expanding targeted toxicological research relevant to vulnerable populations will be crucial for strengthening risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.